Mucosal remodeling and reversibility in chronic rhinosinusitis

Current Opinion in Allergy and Clinical Immunology

Volumn 13, Issue 1, 2013, Pages 4-12

  Bassiouni, Ahmed ^a   Chen, Philip G ^a   Wormald, Peter John ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

chronic rhinosinusitis; dysfunctional sinus; endoscopic sinus surgery; irreversible mucosal disease; mucosal remodeling

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; COLLAGEN; DOXYCYCLINE; FLUTICASONE PROPIONATE; MEPOLIZUMAB; METHYLPREDNISOLONE; MONTELUKAST; PLACEBO; STEROID;

ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BASEMENT MEMBRANE; BIOLOGICAL FUNCTIONS; CHRONIC RHINOSINUSITIS; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE COMPARISON; ENDOSCOPIC SINUS SURGERY; ENDOSCOPIC SURGERY; EOSINOPHILIA; GOBLET CELL; HUMAN; INFLAMMATION; MAXILLARY SINUS; METERED DOSE INHALER; MUCOSA; MUCOSAL REMODELING; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEROID THERAPY; SURGICAL TECHNIQUE;

AIRWAY REMODELING; CHRONIC DISEASE; CYSTEINE; EOSINOPHILIA; HUMANS; LEUKOTRIENES; MATRIX METALLOPROTEINASE 9; RHINITIS; SINUSITIS;

EID: 84871944284     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32835ad09e     Document Type: Review

References (92)

1. Lazarus S. Mild persistent asthma: is any treatment needed? J Allergy Clin Immunol 2006; 118:805-808.
2. Bachert C, Patou J, Van Cauwenberge P. The role of sinus disease in asthma. Curr Opin Allergy Clin Immunol 2006; 6:29-36.
3. Ponikau JU, Sherris DA, Kephart GM, et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histo-pathology similar to asthma? J Allergy Clin Immunol 2003; 112:877-882.
4. Bush A. How early do airway inflammation and remodeling occur? Allergol Int 2008; 57:11-19.
5. Saglani S, Molyneux C, Gong H, et al. Ultrastructure of the reticular basement membrane in asthmatic adults, children and infants. Eur Respir J 2006; 28:505-512.
6. Molet SM, Hamid QA, Hamilos DL. IL-11 and IL-17 expressioninnasal polyps: relationship to collagen deposition and suppression by intranasal fluticasone propionate. Laryngoscope 2003; 113:1803-1812.
7. Barbato A, Turato G, Baraldo S, et al. Airway inflammation in childhood asthma. Am J Respir Crit Care Med 2003; 168:798-803.
8. Bossley CJ, Fleming L, Gupta A, et al. Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines. J Allergy Clin Immunol 2012; 129:974-982; e13.
9. Saglani S, Payne DN, Zhu J, et al. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med 2007; 176:858-864.
10. Boulet LP, Turcotte H, Laviolette M, et al. Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma: influence of inhaled corticosteroids. Am J Respir Crit Care Med 2000; 162 (4 Pt 1):1308-1313.
11. Payne DNR, Rogers AV, Adelroth E, et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med 2003; 167:78-82.
12. Rehl RM, Balla AA, Cabay RJ, et al. Mucosal remodeling in chronic rhinosinusitis. Am J Rhinol 2007; 21:651-657.
13. Sobol SE, Fukakusa M, Christodoulopoulos P, et al. Inflammation and remodeling of the sinus mucosa in children and adults with chronic sinusitis. Laryngoscope 2003; 113:410-414.
14. Chan KH, Abzug MJ, Coffinet L. Chronic rhinosinusitis in young children differs from adults: a histopathology study. J Pediatr 2004; 144:206-212.
15. Zang H-R, Wang T, Li Y-C, et al. A histopathological study: chronic rhino-sinusitis in adolescents versus adults. Zhonghua Yi Xue Za Zhi 2009; 89:1975-1978.
16. Ohno I, Lea RG, Flanders KC, et al. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J Clin Invest 1992; 89:1662-1668.
17. Eisma RJ, Allen JS, Lafreniere D, et al. Eosinophil expression of transforming growth factor-beta and its receptors in nasal polyposis: role of the cytokines in this disease process. Am J Otolaryngol 1997; 18:405-411.
18. Cho JY, Miller M, Baek KJ, et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest 2004; 113:551-560.
19. Tanaka H, Komai M, Nagao K, et al. Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice. Am J Respir Cell Mol Biol 2004; 31:62-68.
20. Humbles AA, Lloyd CM, McMillan SJ, et al. A critical role for eosinophils in allergic airways remodeling. Science 2004; 305:1776-1779.
21. Saitoh T, Kusunoki T, Yao T, et al. Relationship between epithelial damage or basement membrane thickness and eosinophilic infiltration in nasal polyps with chronic rhinosinusitis. Rhinology 2009; 47:275-279.
22. Ward C, Reid DW, Orsida BE, et al. Inter-relationships between airway inflammation, reticular basement membrane thickening and bronchial hyper-reactivity to methacholine in asthma: a systematic bronchoalveolar lavage and airway biopsy analysis. Clin Exp Allergy 2005; 35:1565-1571.
23. Dhong H-J, Kim HY, Cho D-Y. Histopathologic characteristics of chronic sinusitis with bronchial asthma. Acta Otolaryngol 2005; 125:169-176.
24. Ardehali MM, Amali A, Bakhshaee M, et al. The comparison of histopatho-logical characteristics of polyps in asthmatic and nonasthmatic patients. Otolaryngol Head Neck Surg 2009; 140:748-751.
25. Jankowski R, Bouchoua F, Coffinet L, Vignaud JM. Clinical factors influencing the eosinophil infiltration of nasal polyps. Rhinology 2002; 40:173-178.
26. Haruna S, Nakanishi M, Otori N, Moriyama H. Histopathological features of nasal polyps with asthma association: an immunohistochemical study. Am J Rhinol 2004; 18:165-172.
27. Wang QP, Escudier E, Roudot-Thoraval F, et al. Myofibroblast accumulation induced by transforming growth factor-beta is involved in the pathogenesis of nasal polyps. Laryngoscope 1997; 107:926-931.
28. Min YG, Kim YJ, Yun YS. Distribution of eosinophil granule proteins in nasal mucosa of atopic patients with nasal polyposis. ORL J Otorhinolaryngol Relat Spec 1996; 58:82-86.
29. Tosun F, Arslan HH, Karslioglu Y, et al. Relationship between postoperative recurrence rate and eosinophil density of nasal polyps. Ann Otol Rhinol Laryngol 2010; 119:455-459.
30. Nakayama T, Yoshikawa M, Asaka D, et al. Mucosal eosinophilia and recurrence of nasal polyps: new classification of chronic rhinosinusitis. Rhinology 2011; 49:392-396.
31. Ohno I, Ohtani H, Nitta Y, et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997; 16:212-219.
32. Hoshino M, Nakamura Y, Sim J, et al. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol 1998; 102:783-788.
33. Schwingshackl A, Duszyk M, Brown N, Moqbel R. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha. J Allergy Clin Immunol 1999; 104:983-989.
34. Watelet JB, Bachert C, Claeys C, Van Cauwenberge P. Matrix metallo-proteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy 2004; 59:54-60.
35. Mascia K, Borish L, Patrie J, et al. Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2005; 94:652-657.
36. Robinson JL, Griest S, James KE, Smith TL. Impact of aspirin intolerance on outcomes of sinus surgery. Laryngoscope 2007; 117:825-830.
37. Awad OG, Fasano MB, Lee JH, Graham SM. Asthma outcomes after endo-scopic sinus surgery in aspirin-tolerant versus aspirin-induced asthmatic patients. Am J Rhinol 2008; 22:197-203.
38. Mendelsohn D, Jeremic G, Wright ED, Rotenberg BW. Revision rates after endoscopic sinus surgery: a recurrence analysis. Ann Otol Rhinol Laryngol 2011; 120:162-166.
39. Albu S, Tomescu E, Mexca Z, et al. Recurrence rates in endonasal surgery for polyposis. Acta Otorhinolaryngol Belg 2004; 58:79-86.
40. Bassiouni A, Wormald P-J. Role of frontal sinus surgery in nasal polyp recurrence. Laryngoscope (in press).
41. Mudd PA, Katial RK, Alam R, et al. Variations in expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in nasal mucosa of aspirin-sensitive versus aspirin-tolerant patients with nasal poly-posis. Ann Allergy Asthma Immunol 2011; 107:353-359.
42. Steinke JW, Bradley D, Arango P, et al. Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma. J Allergy Clin Immunol 2003; 111:342-349.
43. Kiwamoto T, Ishii Y, Morishima Y, et al. Blockade of cysteinyl leukotriene-1 receptors suppresses airway remodelling in mice overexpressing GATA-3. Clin Exp Allergy 2011; 41:116-128.
44. Corrigan C, Mallett K, Ying S, et al. Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis. J Allergy Clin Immunol 2005; 115:316-322.
45. Sousa AR, Parikh A, Scadding G, et al. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002; 347:1493-1499.
46. Henderson WR Jr, Chiang GKS, Tien Y-T, Chi EY. Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade. Am J Respir Crit Care Med 2006; 173:718-728.
47. Muz MH, Deveci F, Bulut Y, et al. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model. Exp Mol Med 2006; 38:109-118.
48. Baraldo S, Turato G, Bazzan E, et al. Noneosinophilic asthma in children: relation with airway remodelling. Eur Respir J 2011; 38:575-583.
49. Van Bruaene N, Derycke L, Perez-Novo CA, et al. TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol 2009; 124:253-259; 259.e1-2.
50. Li X, Meng J, Qiao X, et al. Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis. J Allergy Clin Immunol 2010; 125:1061-1068.
51. Van Bruaene N, Bachert C. Tissue remodeling in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol 2011; 11:8-11.
52. Zhang N, Van Zele T, Perez-Novo C, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 2008; 122:961-968.
53. Shi J, Fan Y, Xu R, et al. Characterizing T-cell phenotypes in nasal polyposis in Chinese patients. J Investig Allergol Clin Immunol 2009; 19:276-282.
54. Cao P-P, Li H-B, Wang B-F, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol 2009; 124:478-484; 484.e1-2.
55. Nonaka M, Pawankar R, Saji F, Yagi T. Eotaxin synthesis by nasal polyp fibroblasts. Acta Otolaryngol 1999; 119:816-820.
56. Saji F, Nonaka M, Pawankar R. Expression of RANTES by IL-1 beta and TNF-alpha stimulated nasal polyp fibroblasts. Auris Nasus Larynx 2000; 27:247-252.
57. Chakir J, Shannon J, Molet S, et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 2003; 111:1293-1298.
58. Baraket M, Oliver BGG, Burgess JK, et al. Is low dose inhaled corti-costeroid therapy as effective for inflammation and remodeling in asthma? A randomized, parallel group study. Respir Res 2012; 13:11.
59. Chakir J, Loubaki L, Laviolette M, et al. Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study. Eur Respir J 2010; 35:48-53.
60. Mastruzzo C, Greco LR, Nakano K, et al. Impact of intranasal budesonide on immune inflammatoryresponses and epithelial remodeling inchronic upper airway inflammation. J Allergy Clin Immunol 2003; 112:37-44.
61. Ward C, Pais M, Bish R, et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002; 57: 309-316.
62. Olivieri D, Chetta A, Del Donno M, et al. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 1997; 155:1864-1871.
63. Trigg CJ, Manolitsas ND, Wang J, et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994; 150:17-22.
64. Hoshino M, Nakamura Y, Sim JJ, et al. Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma. Clin Exp Allergy 1998; 28:568-577.
65. Flood-Page P, Menzies-Gow A, Phipps S, et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003; 112:1029-1036.
66. Van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol 2010; 125:1069-1076; e4.
67. Toskala E, Rautiainen M. Electron microscopy assessment of the recovery of sinus mucosa after sinus surgery. Acta Otolaryngol 2003; 123:954-959.
68. Thiele A, Holzhausen H-J, Riederer A, Knipping S. Mucosal remodeling in chronic rhinosinusitis without nasal polyposis: an ultrastructural evaluation. Laryngorhinootologie 2010; 89:352-357.
69. Richtsmeier WJ. Top 10 reasons for endoscopic maxillary sinus surgery failure. Laryngoscope 2001; 111 (11 Pt 1):1952-1956.
70. Cho D-Y, Hwang PH. Results of endoscopic maxillary mega-antrostomy in recalcitrant maxillary sinusitis. Am J Rhinol 2008; 22:658-662.
71. Cutler JL, Duncavage JA, Matheny K, et al. Results of Caldwell-Luc after failed endoscopic middle meatus antrostomy in patients with chronic sinusitis. Laryngoscope 2003; 113:2148-2150.
72. Kikawada T, Nonoda T, Matsumoto M, et al. Treatment of intractable diseased tissue in the maxillary sinus after endoscopic sinus surgery with high-pressure water jet and preservation of the periosteum. Arch Otolaryngol Head Neck Surg 2000; 126:55-61.
73. Bassiouni A, Naidoo Y, Wormald P-J. Does mucosal remodeling in chronic rhinosinusitis result in irreversible mucosal disease? Laryngoscope 2012; 122:225-229.
74. Schlosser RJ. Surgical salvage for the nonfunctioning sinus. Otolaryngol Clin North Am 2010; 43:591-604; ix-x.
75. Ragheb S, Duncavage JA. Maxillary sinusitis: value of endoscopic middle meatus antrostomy versus Caldwell-Luc procedure. Operat Tech Otolaryngol Head Neck Surg 1992; 3:129-133.
76. Sathananthar S, Nagaonkar S, Paleri V, et al. Canine fossa puncture and clearance of the maxillary sinus for the severely diseased maxillary sinus. Laryngoscope 2005; 115:1026-1029.
77. Seiberling K, Ooi E, MiinYip J, Wormald P-J. Canine fossa trephine for the severely diseased maxillary sinus. Am J Rhinol Allergy 2009; 23:615-618.
78. Gross WE, Gross CW, Becker D, et al. Modified transnasal endoscopic Lothrop procedure as an alternative to frontal sinus obliteration. Otolaryngol Head Neck Surg 1995; 113:427-434.
79. Wormald PJ. Salvage frontal sinus surgery: the endoscopic modified Lothrop procedure. Laryngoscope 2003; 113:276-283.
80. McFadden EA, Kany RJ, Fink JN, Toohill RJ. Surgery for sinusitis and aspirin triad. Laryngoscope 1990; 100 (10 Pt 1):1043-1046.
81. Seiberling KA, Church CA, Tewfik M, et al. Canine fossa trephine is a beneficial procedure in patients with Samter's triad. Rhinology 2012; 50:104-108.
82. Watelet J-B, Claeys C, Cauwenberge PV, Bachert C. Predictive and monitoring value of matrix metalloproteinase-9 for healing quality after sinus surgery. Wound Repair Regen 2004; 12:412-418.
83. Watelet JB, Demetter P, Claeys C, et al. Neutrophil-derived metallo-proteinase-9 predicts healing quality after sinus surgery. Laryngoscope 2005; 115:56-61.
84. Bassiouni A, Naidoo Y, Wormald P-J. When FESS fails: the inflammatory load hypothesis in refractory chronic rhinosinusitis. Laryngoscope 2012; 122:460-466.
85. Huvenne W, Zhang N, Tijsma E, et al. Pilot study using doxycycline-releasing stents to ameliorate postoperative healing quality after sinus surgery. Wound Repair Regen 2008; 16:757-767.
86. Athanasiadis T, Beule AG, Robinson BH, et al. Effects of a novel chitosan gel on mucosal wound healing following endoscopic sinus surgery in a sheep model of chronic rhinosinusitis. Laryngoscope 2008; 118:1088-1094.
87. Valentine R, Athanasiadis T, Moratti S, et al. The efficacy of a novel chitosan gel on hemostasis and wound healing after endoscopic sinus surgery. Am J Rhinol Allergy 2010; 24:70-75.
88. Rajapakse N, Kim M-M, Mendis E, et al. Carboxylated chitooligosaccharides (CCOS) inhibit MMP-9 expression in human fibrosarcoma cells via down-regulation of AP-1. Biochim Biophys Acta 2006; 1760:1780-1788.
89. Kim M-M, Kim S-K. Chitooligosaccharides inhibit activation and expression of matrix metalloproteinase-2 in human dermal fibroblasts. FEBS Lett 2006; 580:2661-2666.
90. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008; 372:1107-1119.
91. Huvenne W, van Bruaene N, Zhang N, et al. Chronic rhinosinusitis with and without nasal polyps: what is the difference? Curr Allergy Asthma Rep 2009; 9:213-220.
92. Pawankar R, Nonaka M. Inflammatory mechanisms and remodeling in chronic rhinosinusitis and nasal polyps. Curr Allergy Asthma Rep 2007; 7:202-208.